Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2536915 | European Journal of Pharmacology | 2006 | 7 Pages |
Abstract
In the present studies we investigated the mechanism of action of prostaglandin E2 (1Â mg/kg, i.p.) to induce emesis and defecation and/or tenesmus in the ferret. The emesis was antagonized significantly (PÂ <Â 0.05) by ondansetron (0.3 and 1Â mg/kg, i.p.) and (+)-(2S,3S)-3-(2-methoxybenzylamino)-2-phenlypiperidine hydrochloride (CP-99,994; 10Â mg/kg, i.p.), but neither compound reduced defecations and/or tenesmus, with ondansetron (0.3Â mg/kg) actually producing a slight increase (PÂ <Â 0.05). Droperidol (1 and 3Â mg/kg), metoclopramide (0.3 and 3Â mg/kg), domperidone (0.3 and 3Â mg/kg), promethazine (0.3 and 3Â mg/kg) and scopolamine (0.3 and 3Â mg/kg) failed to reduce prostaglandin E2 induced emesis. However, droperidol (1 and 3Â mg/kg) and scopolamine (0.3 and 3Â mg/kg) reduced significantly the defecatory and/or tenesmus response (PÂ <Â 0.05). Bilateral abdominal vagotomy was ineffective to reduce emesis and defecations and/or tenesmus. The data suggests that 5-HT3 receptor and NK1 tachykinin receptor antagonists could be useful in the clinic to prevent emesis but not defecations induced by prostaglandin E2.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Kelvin K.W. Kan, John A. Rudd, Man K. Wai,